Inovio Pharmaceuticals's total assets for Q1 2025 were $87.27M, a decrease of -22.90% from the previous quarter. INO total liabilities were $36.02M for the fiscal quarter, a -19.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.